🟢 HCW Biologics is trading 14.56% up in pre-market; no verified company-specific catalyst identified

HCW Biologics is trading at $3.37, up +14.56%, with no verified September 8, 2026 company-specific catalyst identified.

• The latest confirmed announcement was a September 2 patent allowance for HCW9302’s alopecia areata treatment claims.
• Broader markets are mixed, making a clear macro explanation unlikely.
• No reliable volume or activity data was available.